活体供体肝移植后的外流阻塞用临时静脉过器进行管理:一个病例报告
Yitian Fang1, Adriaan Moelker2, Caroline M den Hoed3
1Erasmus MC Transplant Institute, Department of Surgery, Division of HPB and Transplant Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
International journal of surgery case reports
|October 26, 2023
概括
在活体供体肝移植 (LDLT) 后,静脉膜过器成功地控制了导致外流阻塞的逆肝压缩. 这种最少的侵入性方法解决了瘤,并保留了移植功能,在移植后安全地去除过器.
科学领域:
- 肝胆道手术 肝胆道手术
- 移植手术 移植手术
- 血管外科 血管外科
背景情况:
- 输出阻塞是肝移植中关键的血管并发症,可能导致移植损失和死亡.
- 逆肝马脉压缩是肝移植后流出阻塞的一个罕见原因.
- 大规模的炎可能是骑马静脉外流阻塞的表现症状.
研究的目的:
- 在活体供体肝移植 (LDLT) 后报告马脉外流阻塞病例.
- 描述使用临时静脉膜过器成功管理逆肝压缩.
- 突出一种最小的侵入性方法来管理移植后的血管并发症.
主要方法:
- 一名63岁的男性接受了右叶LDLT治疗,以治疗末期肝病.
- 移植后12天出现了马脉外流阻塞和巨大的.
- 在压缩部位通过横通道植入 vena cava 过器.
主要成果:
- 干预后,患者的大型瘤明显减少.
- 在静脉腔镜植入后,移植功能保持稳定.
- 静脉洞过器在移植后的第50天被安全地移除,患者的出院成功.
结论:
- 肝移植后压缩外流阻塞需要量身定制的管理策略.
- 临时静脉膜过器植入是一种可行的最小侵入性选择,用于管理压缩性马脉阻塞.
- 这种方法可以有效地解决症状,并保持移植活力在选定的情况下.
相关概念视频
Kidney Transplant II: Surgical Procedure
20
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
20
Hemodialysis I: Introduction
36
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
36
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14


